Institute of Neuroimmunology at SAS
Norbert Žilka has been with AXON Neuroscience SE since its establishment in 1999. He has played a key role in guiding discoveries and has helped transform portfolio of products, which eventually led to his appointment as chief scientific officer in 2015. He is also Member of the Board of Directors of Axon Neuroscience R&D Services SE.
He has co-authored the project Synaptic Dysfunction in Alzheimer’s Disease (Marie Curie Innovative Training Network). In addition, he serves as the national coordinator and Chairman of the Neuroscience session at the first Frontiers of Science Meeting.
He holds a PhD in Immunology from the Slovak Academy of Sciences (SAS) and is an associate professor at the Institute of Neuroimmunology at SAS.
SLOBLOCO 2020 Topic: Blockchain in praxis – coronavirus vaccine